Baker Bros. Advisors (gp) Llc - Net Worth and Insider Trading
Baker Bros. Advisors (gp) Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Baker Bros. Advisors (gp) Llc owns 29 companies in total, including IGM Biosciences Inc (IGMS) , Incyte Corp (INCY) , and Kodiak Sciences Inc (KOD) among others .
Click here to see the complete history of Baker Bros. Advisors (gp) Llc’s form 4 insider trades.
Insider Ownership Summary of Baker Bros. Advisors (gp) Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IGMS | IGM Biosciences Inc | 2022-03-12 | director & 10 percent owner |
| INCY | Incyte Corp | 2013-07-01 | director & 10 percent owner |
| KOD | Kodiak Sciences Inc | 2022-01-21 | director & 10 percent owner |
 | | 2022-06-17 | director & 10 percent owner |
| | 2022-06-29 | director |
| | 2023-10-19 | other: Former 10% Owner |
| | 2016-02-02 | director & 10 percent owner |
| | 2013-07-01 | director & 10 percent owner |
| | 2020-12-31 | director & 10 percent owner |
| | 2020-05-14 | director |
| | 2020-03-16 | director |
| | 2015-08-07 | 10 percent owner |
| | 2014-03-10 | director |
| | 2019-04-17 | 10 percent owner |
| | 2018-09-13 | 10 percent owner |
| | 2015-08-27 | 10 percent owner |
| | 2015-12-24 | 10 percent owner |
| | 2013-07-09 | 10 percent owner |
| | 2017-10-04 | 10 percent owner |
| | 2013-07-01 | 10 percent owner |
| | 2016-05-05 | 10 percent owner |
| | 2013-07-01 | director & 10 percent owner |
| | 2013-07-01 | director & 10 percent owner |
| | 2022-06-10 | director & 10 percent owner |
| | 2022-06-13 | director & 10 percent owner |
| | 2021-02-23 | director |
| | 2022-05-16 | 10 percent owner |
| | 2022-05-10 | director & 10 percent owner |
| | 2023-06-15 | director |
Baker Bros. Advisors (gp) Llc Trading Performance
Baker Bros. Advisors (gp) Llc Ownership Network
Baker Bros. Advisors (gp) Llc Owned Company Details
What does IGM Biosciences Inc do?
Who are the key executives at IGM Biosciences Inc?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include director & 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Steven Weber , and Chief Medical Officer Chris H Takimoto .
IGM Biosciences Inc (IGMS) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 11,918 shares made by George Gauthier , a net sale of 20,975 shares made by Bruce Keyt , and a net sale of 14,987 shares made by Lisa Lynn Decker .
In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc (IGMS) in total and bought 395,317 shares, with a net purchase of 367,192 shares. During the past 18 months, 204,745 shares of IGM Biosciences Inc (IGMS) were sold and 1,190,933 shares were bought by its insiders, resulting in a net purchase of 986,188 shares.
IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
IGM Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Incyte Corp do?
Who are the key executives at Incyte Corp?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of Incyte Corp. Other key executives at Incyte Corp include EVP & Chief Medical Officer Steven H Stein , EVP GPS & BD & & Licensing Vijay K Iyengar , and Principal Accounting Officer Thomas Tray .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .
In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
- Download to Excel(.xls)
What does Kodiak Sciences Inc do?
Who are the key executives at Kodiak Sciences Inc?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of Kodiak Sciences Inc. Other key executives at Kodiak Sciences Inc include See Remarks Jason Ehrlich , See Remarks John A. Borgeson , and director & 10 percent owner Baker Bros. Advisors Lp .
Kodiak Sciences Inc (KOD) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Kodiak Sciences Inc (KOD). Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 4,197 shares made by John A. Borgeson , and a net sale of 3,390 shares made by Jason Ehrlich .
In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,587 shares of Kodiak Sciences Inc (KOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,587 shares.
Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kodiak Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include director & President & CEO Krishna Vaddi , Chief Legal Counsel & Corp Sec. Bryant David Lim , and Chief Financial Officer Laurent Chardonnet .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 32,944 shares made by Krishna Vaddi , a net purchase of 15,000 shares made by Laurent Chardonnet , and a net purchase of 869,565 shares made by David P Bonita .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,280 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,789,474 shares were bought by its insiders, resulting in a net purchase of 1,776,194 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Kiniksa Pharmaceuticals Ltd do?
Who are the key executives at Kiniksa Pharmaceuticals Ltd?
Baker Bros. Advisors (gp) Llc is the director of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.
Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals Ltd Insider Transactions
- Download to Excel(.xls)
What does Atreca Inc do?
Who are the key executives at Atreca Inc?
Baker Bros. Advisors (gp) Llc is the other: Former 10% Owner of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .
Atreca Inc (BCEL) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 20,788 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 20,788 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.
Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atreca Inc Insider Transactions
- Download to Excel(.xls)
What does BeiGene Ltd do?
Who are the key executives at BeiGene Ltd?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of BeiGene Ltd. Other key executives at BeiGene Ltd include director & 10 percent owner & Chief Executive Office John Oyler , Chief Financial Officer Julia Aijun Wang , and director & 10 percent owner Baker Bros. Advisors Lp .
BeiGene Ltd (BGNE) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 159,928 shares made by John Oyler , a net sale of 82,635 shares made by Xiaodong Wang , and a net sale of 13,539 shares made by Xiaobin Wu .
In summary, during the past 3 months, insiders sold 100,397 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 100,397 shares. During the past 18 months, 5,517,082 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,517,082 shares.
BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
BeiGene Ltd Insider Transactions
- Download to Excel(.xls)
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Principal Accounting Officer James Kihara , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 300,905 shares made by Stephen Davis , a net sale of 32,184 shares made by Brendan Teehan , and a net sale of 17,770 shares made by James Kihara .
In summary, during the past 3 months, insiders sold 69,383 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 69,383 shares. During the past 18 months, 433,237 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 463,285 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,447 shares made by Jean I Liu , a net sale of 46,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 413,479 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 413,479 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
- Download to Excel(.xls)
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Baker Bros. Advisors (gp) Llc is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Zymeworks Inc do?
Who are the key executives at Zymeworks Inc?
Baker Bros. Advisors (gp) Llc is the director of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .
Zymeworks Inc (ZYME) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 5,868,900 shares made by Ecor1 Capital, Llc , a net sale of 8,654 shares made by Christopher Astle , and a net sale of 7,425 shares made by Neil Josephson .
In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 52,759 shares of Zymeworks Inc (ZYME) were sold and 5,868,900 shares were bought by its insiders, resulting in a net purchase of 5,816,141 shares.
Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zymeworks Inc Insider Transactions
- Download to Excel(.xls)
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Aceragen Inc do?
Who are the key executives at Aceragen Inc?
Baker Bros. Advisors (gp) Llc is the director of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .
Aceragen Inc (ACGN) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .
In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.
Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aceragen Inc Insider Transactions
- Download to Excel(.xls)
What does HOOKIPA Pharma Inc do?
Who are the key executives at HOOKIPA Pharma Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .
HOOKIPA Pharma Inc (HOOK) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .
In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.
HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
HOOKIPA Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Development Officer Stefani Wolff , director & President & CEO Martin Babler , and Chief Medical Officer Dolca Thomas .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does Invitae Corp do?
Who are the key executives at Invitae Corp?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .
Invitae Corp (NVTAQ) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .
In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.
Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invitae Corp Insider Transactions
- Download to Excel(.xls)
What does Bellicum Pharmaceuticals Inc do?
Who are the key executives at Bellicum Pharmaceuticals Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .
Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellicum Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , Chief Technical Officer Joseph Shulman , and EVP & Head of North America Jennifer Chien .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .
In summary, during the past 3 months, insiders sold 243,187 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 243,187 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include director & CEO Jon P Stonehouse , Vice President and CCO Charles K Gayer , and Exec Director & Finance - PAO Michael L Jones .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and director & President and CEO John M. Leonard .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .
In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does XOMA Corp do?
Who are the key executives at XOMA Corp?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of XOMA Corp. Other key executives at XOMA Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and other: See Explanation of Responses Biotechnology Value Fund L P .
XOMA Corp (XOMA) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in XOMA Corp (XOMA). Other recent insider transactions involving XOMA Corp (XOMA) include a net purchase of 9,100 shares made by Bradley Sitko , a net purchase of 5,500 shares made by Owen Hughes , and a net purchase of 22,249 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMA) were sold and 36,849 shares were bought by its insiders, resulting in a net purchase of 36,849 shares.
XOMA Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Corp Insider Transactions
- Download to Excel(.xls)
What does XOMA Corp do?
Who are the key executives at XOMA Corp?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of XOMA Corp. Other key executives at XOMA Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and 10 percent owner Bvf Ii Gp Llc .
XOMA Corp (XOMAO.PFD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XOMA Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Corp Insider Transactions
- Download to Excel(.xls)
What does Talis Biomedical Corp do?
Who are the key executives at Talis Biomedical Corp?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of Talis Biomedical Corp. Other key executives at Talis Biomedical Corp include President & other: Chief Scientific Officer Andrew A Lukowiak , Interim CFO Rebecca Markovich , and director & 10 percent owner Julian Baker .
Talis Biomedical Corp (TLIS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talis Biomedical Corp Insider Transactions
- Download to Excel(.xls)
What does DBV Technologies SA do?
Who are the key executives at DBV Technologies SA?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of DBV Technologies SA. Other key executives at DBV Technologies SA include director & Chief Executive Officer Daniel Tasse , Chief Medical Officer Pharis Mohideen , and Chief Financial Officer Virginie Boucinha .
DBV Technologies SA (DBVT) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in DBV Technologies SA (DBVT). Other recent insider transactions involving DBV Technologies SA (DBVT) include a net sale of 4,506 shares made by Pharis Mohideen , a net purchase of 17,094 shares made by Daniel Tasse , and a net purchase of 15,000 shares made by Daniel B Soland .
In summary, during the past 3 months, insiders sold 0 shares of DBV Technologies SA (DBVT) in total and bought 18,919 shares, with a net purchase of 18,919 shares. During the past 18 months, 4,506 shares of DBV Technologies SA (DBVT) were sold and 45,919 shares were bought by its insiders, resulting in a net purchase of 41,413 shares.
DBV Technologies SA (DBVT)'s detailed insider trading history can be found in Insider Trading Tracker table.
DBV Technologies SA Insider Transactions
- Download to Excel(.xls)
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the director of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Entrada Therapeutics Inc do?
Who are the key executives at Entrada Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the 10 percent owner of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Operating Officer Nathan J Dowden , Chief Financial Officer Kory James Wentworth , and director & President and CEO Dipal Doshi .
Entrada Therapeutics Inc (TRDA) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 34,092 shares made by Dipal Doshi , a net sale of 52,896 shares made by Kory James Wentworth , and a net sale of 25,877 shares made by Nathan J Dowden .
In summary, during the past 3 months, insiders sold 6,912 shares of Entrada Therapeutics Inc (TRDA) in total and bought 15,892 shares, with a net purchase of 8,980 shares. During the past 18 months, 167,506 shares of Entrada Therapeutics Inc (TRDA) were sold and 15,892 shares were bought by its insiders, resulting in a net sale of 151,614 shares.
Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entrada Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does TScan Therapeutics Inc do?
Who are the key executives at TScan Therapeutics Inc?
Baker Bros. Advisors (gp) Llc is the director & 10 percent owner of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Accounting Officer Leiden Dworak , 10 percent owner Weston Nichols , and 10 percent owner Lynx1 Capital Management Lp .
TScan Therapeutics Inc (TCRX) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net sale of 25,400 shares made by Lynx1 Capital Management Lp , and a net purchase of 6,000 shares made by Brian M. Silver .
In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,400 shares of TScan Therapeutics Inc (TCRX) were sold and 78,027 shares were bought by its insiders, resulting in a net purchase of 52,627 shares.
TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TScan Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Madrigal Pharmaceuticals Inc do?
Who are the key executives at Madrigal Pharmaceuticals Inc?
Baker Bros. Advisors (gp) Llc is the director of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & Chief Executive Officer Paul A Friedman , director & Chief Medical Officer & EVP R&D Rebecca Taub , and Senior VP & Chief Pharma Dev. Robert E. Waltermire .
Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary
Over the past 18 months, Baker Bros. Advisors (gp) Llc made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 29,800 shares made by Brian Joseph Lynch , and a net sale of 100,000 shares made by Paul A Friedman .
In summary, during the past 3 months, insiders sold 252,542 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 252,542 shares. During the past 18 months, 342,631 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 82,054 shares.
Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Madrigal Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
Baker Bros. Advisors (gp) Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Baker Bros. Advisors (gp) Llc. You might contact Baker Bros. Advisors (gp) Llc via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
